Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Chris Lavy led the first Africa Clubfoot Training (ACT) project training courses in Ethiopia last month, with an international team of orthopaedic surgeons and physiotherapists from the UK, Ethiopia, the Netherlands, Zimbabwe and Norway.

The team delivered a two-day basic provider course and one-day advanced provider course at the CURE Ethiopia Children's Hospital to train 31 surgical residents, doctors, physiotherapists, and nurses in the Ponseti method of clubfoot treatment.

The goal of the ACT project is to scale up clubfoot training capacity, not only in Ethiopia, but also across the region, so that more children born with clubfoot can access treatment.

Clubfoot is a common condition that occurs in approximately 1 in 700 births in Africa. If untreated, the condition deteriorates and children can be left with painful deformity.

ACT Training

The UK Department for International Development awarded the ACT project partners two years of funding in March 2015 through the Health Partnership Scheme to train more local instructors and to develop standardised clubfoot provider and instructor training materials for use throughout sub-Saharan Africa.

The University of Oxford (lead partner) are working with ACT project partners CURE Ethiopia Children's Hospital, the CURE Clubfoot Africa programme, and Global Clubfoot Initiative (a consortium of clubfoot provider and training organisations) to develop the resources, and also drawing on expertise from experienced clubfoot practitioners in the UK and Africa.

This course was the first of a series of pilot courses of the training materials which will continue through 2016, with the resources finalised by early 2017.

© Images courtesy of CURE Clubfoot

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.